Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding HELX?
Track your performance easily
HELX Price & Analysis
HELX ETF Chart & Stats
Day’s Range― - ―
52-Week Range$25.26 - $32.92
Previous Close$30.65
VolumeN/A
Average Volume (3M)834.00
AUM9.20M
NAV30.47
Expense Ratio0.50%
Holdings Count61
Beta1.10
Inception DateFeb 25, 2020
Last Dividend Ex-Date
Dec 30, 2021Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.08
10 Day Avg. Volume520
30 Day Avg. Volume834
Alpha-0.00512
Franklin Genomic Advancements ETF (HELX) Fund Flow Chart
Franklin Genomic Advancements ETF (HELX) 1 year Net Flows: -$400K
HELX ETF News
HELX ETF FAQ
What was HELX’s price range in the past 12 months?
HELX lowest ETF price was $25.26 and its highest was $32.92 in the past 12 months.
What is the AUM of HELX?
As of Apr 24, 2024 The AUM of HELX is 9.20M.
Is HELX overvalued?
According to Wall Street analysts HELX’s price is currently Undervalued.
Does HELX pay dividends?
HELX pays a Annually dividend of <$0.01 which represents an annual dividend yield of N/A. See more information on HELX dividends here
How many shares outstanding does HELX have?
Currently, no data Available
Which hedge fund is a major shareholder of HELX?
Currently, no hedge funds are holding shares in HELX
HELX ETF Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Medpace Holdings Inc
7.98%
Thermo Fisher Scientific
4.91%
Vertex Pharmaceuticals Inc.
4.78%
Regeneron Pharmaceuticals
4.55%
Danaher Corporation
4.25%
Eli Lilly And Company
4.24%
Krystal Biotech, Inc.
4.09%
Bruker Corporation
3.20%
SAMSUNG BIOLOGICS Co., Ltd.
3.05%
Natera Inc.
2.96%
Total44.01%
ETF Description
Franklin Genomic Advancements ETF
HELX is an actively managed portfolio of global equity securities of companies relevant to genomic discovery.